SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Roger Cranwill who wrote (860)5/13/1997 10:16:00 PM
From: I. Luttichuys   of 1762
 
Hello Roger... CE9.1 is being studied for two indications... RA and severe asthma. Asthma is in Phase II. Brad is alluding to the possibility that perhaps IDEC may release some information on the severe asthma side which has been very quiet since I have been a shareholder. It must be remembered that the recent string of posts are speculation based on the assumption that IDEC does have information to release next week. I think we do know, however, that something in the way of these results is due to be released at some point this month. Rick, who first posted on this subject, made it clear that this was by no means confirmed regarding this week but he will keep us informed as to what he further discovers.
Will you be at the stockholder's meeting, Roger? The thought to go has occured to me as I will be done with tests here. I might like to attend.
BENNETT
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News